1. Cabazitaxel multiple rechallenges in metastatic castration‐resistant prostate cancer. (12th August 2021) Authors: Pobel, Cedric; Auclin, Edouard; Teyssonneau, Diego; Laguerre, Brigitte; Cancel, Mathilde; Boughalem, Elouen; Noel, Johanna; Brachet, Pierre Emmanuel; Maillet, Denis; Barthelemy, Philippe; Helissey, Carole; Thibault, Constance; Oudard, Stéphane Journal: Cancer medicine Issue: Volume 10:Number 18(2021) Page Start: 6304 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of regorafenib in patients with metastatic or locally advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II study. (June 2021) Authors: Duffaud, Florence; Italiano, Antoine; Bompas, Emannuelle; Rios, Maria; Penel, Nicolas; Mir, Olivier; Piperno-Neumann, Sophie; Chevreau, Christine; Delcambre, Corinne; Bertucci, François; Boudou-Rouquette, Pascaline; Cancel, Mathilde; Perrin, Christophe; Saada-Bouzid, Esma; Monard, Laure; Schiffle... Journal: European journal of cancer Issue: Volume 150(2021) Page Start: 108 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Everolimus or sunitinib as first-line treatment of metastatic papillary renal cell carcinoma: A retrospective study of the GETUG group (Groupe d'Etude des Tumeurs Uro-Génitales). (November 2021) Authors: Cancel, Mathilde; Fromont, Gaelle; Blonz, Cyriac; Chevreau, Christine; Rioux-Leclercq, Nathalie; Laguerre, Brigitte; Oudard, Stéphane; Gross-Goupil, Marine; Gravis, Gwenaelle; Goldwasser, François; Rolland, Frédéric; Delva, Rémy; Moise, Laura; Emambux, Sheik; Vassal, Cécile; Zanetta, Sylvie; Pene... Journal: European journal of cancer Issue: Volume 158(2021) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Preservation of quality of life in patients with human epidermal growth factor receptor 2–positive metastatic breast cancer treated with tucatinib or placebo when added to trastuzumab and capecitabine (HER2CLIMB trial). (August 2021) Authors: Mueller, Volkmar; Wardley, Andrew; Paplomata, Elisavet; Hamilton, Erika; Zelnak, Amelia; Fehrenbacher, Louis; Jakobsen, Erik; Curtit, Elsa; Boyle, Frances; Harder Brix, Eva; Brenner, Andrew; Crouzet, Laurence; Ferrario, Cristiano; Muñoz-Mateu, Montserrat; Arkenau, Hendrik-Tobias; Iqbal, Nayyer; A... Journal: European journal of cancer Issue: Volume 153(2021) Page Start: 223 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗